Home › Companies › The Oncology Institute, Inc. › 2025-2026

The Oncology Institute, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and The Oncology Institute, Inc.’s Form 8-K, filed June 18, 2026 (Item 5.07 on EDGAR). Page generated October 25, 2026.

  • 11Reported items
  • 109Asset managers
  • 1,337Fund votes
  • June 17, 2026Meeting date

Results at a glance

Meeting of June 17, 2026: 10 items on The Oncology Institute, Inc.’s Form 8-K, filed June 18, 2026: 2 approved · 8 without a stated outcome.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2025-2026

Explore The Oncology Institute, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by The Oncology Institute, Inc.

These tallies are The Oncology Institute, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 18, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

The Oncology Institute, Inc. — official shareholder meeting results, meeting held June 17, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Brad Hively 24,098,631---- 1,477,08449,666,722 94%Not verified—
Elect Director: Karen Johnson 23,014,174---- 2,561,54149,666,722 90%Not verified—
Elect Director: Mohit Kaushal 24,061,396---- 1,514,31949,666,722 94%Not verified—
Elect Director: Anne McGeorge 24,062,503---- 1,513,21249,666,722 94%Not verified—
Elect Director: Mark Pacala 24,068,647---- 1,507,06849,666,722 94%Not verified—
Elect Director: Mark Stolper 24,102,389---- 1,473,32649,666,722 94%Not verified—
Elect Director: Kimberly Tzoumakas 24,102,880---- 1,472,83549,666,722 94%Not verified—
Elect Director: Daniel Virnich 25,528,398---- 47,31749,666,722 99.8%Not verified—
2. Ratification of the Appointment of Independent Registered Public Accountants The ratification of the appointment of BDO USA, P.C 75,098,89037,257106,290 ---- 99.9%Approved—
3. Approval, on a non-binding, advisory basis, of the Company's named executive officers (the "Say-on-Pay Proposal") The Say-on-Pay Proposal 25,280,934282,65512,126 --49,666,722 99%Approved—

Source: The Oncology Institute, Inc., Form 8-K, filed with the SEC on June 18, 2026 — read the filing on EDGAR.

How asset managers voted at the The Oncology Institute, Inc. 2025-2026 meeting

Each item below shows how the 109 asset managers that disclosed a The Oncology Institute, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of The Oncology Institute, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Director: Anne McGeorge

Outcome not verifiedFund totals may overlapDIRECTOR ELECTIONSReported outcome: Not verified

Combines 4 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 24,062,503WITHHELD: 1,513,212
Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: Election of eight directors: Anne McGeorge

The Oncology Institute, Inc.’s own tally for this item (“Elect Director: Anne McGeorge”): 24,062,503 for, 1,513,212 withheld, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 39 asset managers voting on “Election of eight directors: Anne McGeorge” at The Oncology Institute, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,180,4090 78,184For
BlackRock1,378,0860 00For
World Funds Trust1,000,0000 00For
TIFF INVESTMENT PROGRAM352,8490 00For
Charles Schwab214,8900 00For
Goldman Sachs178,7260 00For
JPMorgan98,0100 00For
Equitable82,5610 00For
Lincoln Financial74,5380 00For
Fidelity43,0460 00For
AQR39,6750 00For
QUANTITATIVE MASTER SERIES LLC39,6380 00For
Global X34,5750 00For
Voya31,7720 00For
Pacific Life23,9010 00For
John Hancock19,8180 00For
Brighthouse17,1430 00For
GPS Funds I15,8390 00For
Bridge Builder Trust14,0400 00For
ProShares11,7040 00For
TIAA8,8100 00For
Northern Trust8,6860 00For
SEI7,6000 00For
Victory Capital7,3860 00For
AIG/SunAmerica6,8460 00For

Fund voting reports, all 39 managers: 7,916,577 for, 14,634 withheld, 7 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 1 asset manager voting on “Election of eight directors: Anne McGeorge” at The Oncology Institute, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Kanen Wealth Management LLC3,513,1780 00For

Institutional-manager reports, all 1 managers: 3,513,178 for.

2. Elect Director: Brad Hively

Outcome not verifiedFund totals may overlapDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 24,098,631WITHHELD: 1,477,084
Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: Election of eight directors: Brad Hively

The Oncology Institute, Inc.’s own tally for this item (“Elect Director: Brad Hively”): 24,098,631 for, 1,477,084 withheld, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 39 asset managers voting on “Election of eight directors: Brad Hively” at The Oncology Institute, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,183,0990 75,495For
BlackRock1,378,0860 00For
World Funds Trust1,000,0000 00For
TIFF INVESTMENT PROGRAM352,8490 00For
Charles Schwab214,8900 00For
Goldman Sachs178,7260 00For
JPMorgan98,0100 00For
Equitable82,5610 00For
Lincoln Financial74,5380 00For
Fidelity43,0460 00For
AQR39,6750 00For
QUANTITATIVE MASTER SERIES LLC39,6380 00For
Global X34,5750 00For
Voya31,7720 00For
Pacific Life23,9010 00For
John Hancock19,8180 00For
Brighthouse17,1430 00For
GPS Funds I15,8390 00For
Bridge Builder Trust14,0400 00For
ProShares11,7040 00For
TIAA8,8100 00For
Northern Trust8,6860 00For
SEI7,6000 00For
Victory Capital7,3860 00For
AIG/SunAmerica6,8460 00For

Fund voting reports, all 39 managers: 7,925,293 for, 5,919 withheld, 7 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 1 asset manager voting on “Election of eight directors: Brad Hively” at The Oncology Institute, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Kanen Wealth Management LLC3,513,1780 00For

Institutional-manager reports, all 1 managers: 3,513,178 for.

3. Elect Director: Daniel Virnich

Outcome not verifiedFund totals may overlapDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%
FOR: 25,528,398WITHHELD: 47,317
Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: Election of eight directors: Daniel Virnich

The Oncology Institute, Inc.’s own tally for this item (“Elect Director: Daniel Virnich”): 25,528,398 for, 47,317 withheld, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.8% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 39 asset managers voting on “Election of eight directors: Daniel Virnich” at The Oncology Institute, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,188,6010 00For
BlackRock1,378,0860 00For
World Funds Trust1,000,0000 00For
TIFF INVESTMENT PROGRAM352,8490 00For
Charles Schwab214,8900 00For
Goldman Sachs178,7260 00For
JPMorgan98,0100 00For
Equitable82,5610 00For
Lincoln Financial74,5380 00For
Fidelity43,0460 00For
AQR39,6750 00For
QUANTITATIVE MASTER SERIES LLC39,6380 00For
Global X34,5750 00For
Voya31,7720 00For
Pacific Life23,9010 00For
John Hancock19,8180 00For
Brighthouse17,1430 00For
GPS Funds I15,8390 00For
Bridge Builder Trust14,0400 00For
ProShares11,7040 00For
TIAA8,8100 00For
Northern Trust8,6860 00For
SEI7,6000 00For
Victory Capital7,3860 00For
AIG/SunAmerica6,8460 00For

Fund voting reports, all 39 managers: 7,931,219 for. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 1 asset manager voting on “Election of eight directors: Daniel Virnich” at The Oncology Institute, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Kanen Wealth Management LLC3,513,1780 00For

Institutional-manager reports, all 1 managers: 3,513,178 for.

4. Elect Director: Karen Johnson

Outcome not verifiedFund totals may overlapDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

FOR 90%
FOR: 23,014,174WITHHELD: 2,561,541
Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: Election of eight directors: Karen Johnson

The Oncology Institute, Inc.’s own tally for this item (“Elect Director: Karen Johnson”): 23,014,174 for, 2,561,541 withheld, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 90% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 39 asset managers voting on “Election of eight directors: Karen Johnson” at The Oncology Institute, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,183,0940 125,495For
BlackRock1,378,0860 00For
World Funds Trust1,000,0000 00For
TIFF INVESTMENT PROGRAM352,8490 00For
Charles Schwab214,8900 00For
Goldman Sachs178,7260 00For
JPMorgan98,0100 00For
Equitable82,5610 00For
Lincoln Financial74,5380 00For
Fidelity43,0460 00For
AQR00 039,675Withhold
QUANTITATIVE MASTER SERIES LLC39,6380 00For
Global X34,5750 00For
Voya00 031,772Withhold
Pacific Life23,9010 00For
John Hancock00 019,818Withhold
Brighthouse00 017,143Withhold
GPS Funds I15,8390 00For
Bridge Builder Trust14,0400 00For
ProShares00 011,704Withhold
TIAA8,8100 00For
Northern Trust8,6860 00For
SEI7,6000 00For
Victory Capital00 07,386Withhold
AIG/SunAmerica00 06,846Withhold

Fund voting reports, all 39 managers: 7,778,944 for, 152,263 withheld, 12 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 1 asset manager voting on “Election of eight directors: Karen Johnson” at The Oncology Institute, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Kanen Wealth Management LLC3,513,1780 00For

Institutional-manager reports, all 1 managers: 3,513,178 for.

5. Elect Director: Kimberly Tzoumakas

Outcome not verifiedFund totals may overlapDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 24,102,880WITHHELD: 1,472,835
Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: Election of eight directors: Kimberly Tzoumakas

The Oncology Institute, Inc.’s own tally for this item (“Elect Director: Kimberly Tzoumakas”): 24,102,880 for, 1,472,835 withheld, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 39 asset managers voting on “Election of eight directors: Kimberly Tzoumakas” at The Oncology Institute, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,188,5940 70For
BlackRock1,378,0860 00For
World Funds Trust1,000,0000 00For
TIFF INVESTMENT PROGRAM352,8490 00For
Charles Schwab214,8900 00For
Goldman Sachs178,7260 00For
JPMorgan98,0100 00For
Equitable82,5610 00For
Lincoln Financial74,5380 00For
Fidelity43,0460 00For
AQR39,6750 00For
QUANTITATIVE MASTER SERIES LLC39,6380 00For
Global X34,5750 00For
Voya31,7720 00For
Pacific Life23,9010 00For
John Hancock19,8180 00For
Brighthouse17,1430 00For
GPS Funds I15,8390 00For
Bridge Builder Trust14,0400 00For
ProShares11,7040 00For
TIAA8,8100 00For
Northern Trust8,6860 00For
SEI7,6000 00For
Victory Capital7,3860 00For
AIG/SunAmerica6,8460 00For

Fund voting reports, all 39 managers: 7,931,212 for, 7 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 1 asset manager voting on “Election of eight directors: Kimberly Tzoumakas” at The Oncology Institute, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Kanen Wealth Management LLC3,513,1780 00For

Institutional-manager reports, all 1 managers: 3,513,178 for.

6. Elect Director: Mark Pacala

Outcome not verifiedFund totals may overlapDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 24,068,647WITHHELD: 1,507,068
Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: Election of eight directors: Mark Pacala

The Oncology Institute, Inc.’s own tally for this item (“Elect Director: Mark Pacala”): 24,068,647 for, 1,507,068 withheld, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 39 asset managers voting on “Election of eight directors: Mark Pacala” at The Oncology Institute, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,183,0990 75,495For
BlackRock1,378,0860 00For
World Funds Trust1,000,0000 00For
TIFF INVESTMENT PROGRAM352,8490 00For
Charles Schwab214,8900 00For
Goldman Sachs178,7260 00For
JPMorgan98,0100 00For
Equitable82,5610 00For
Lincoln Financial74,5380 00For
Fidelity43,0460 00For
AQR39,6750 00For
QUANTITATIVE MASTER SERIES LLC39,6380 00For
Global X34,5750 00For
Voya31,7720 00For
Pacific Life23,9010 00For
John Hancock19,8180 00For
Brighthouse17,1430 00For
GPS Funds I15,8390 00For
Bridge Builder Trust14,0400 00For
ProShares11,7040 00For
TIAA8,8100 00For
Northern Trust8,6860 00For
SEI7,6000 00For
Victory Capital7,3860 00For
AIG/SunAmerica6,8460 00For

Fund voting reports, all 39 managers: 7,925,293 for, 5,919 withheld, 7 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 1 asset manager voting on “Election of eight directors: Mark Pacala” at The Oncology Institute, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Kanen Wealth Management LLC3,513,1780 00For

Institutional-manager reports, all 1 managers: 3,513,178 for.

7. Elect Director: Mark Stolper

Outcome not verifiedFund totals may overlapDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 24,102,389WITHHELD: 1,473,326
Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: Election of eight directors: Mark Stolper

The Oncology Institute, Inc.’s own tally for this item (“Elect Director: Mark Stolper”): 24,102,389 for, 1,473,326 withheld, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 39 asset managers voting on “Election of eight directors: Mark Stolper” at The Oncology Institute, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,185,9040 72,690For
BlackRock1,378,0860 00For
World Funds Trust1,000,0000 00For
TIFF INVESTMENT PROGRAM352,8490 00For
Charles Schwab214,8900 00For
Goldman Sachs178,7260 00For
JPMorgan98,0100 00For
Equitable82,5610 00For
Lincoln Financial74,5380 00For
Fidelity43,0460 00For
AQR39,6750 00For
QUANTITATIVE MASTER SERIES LLC39,6380 00For
Global X34,5750 00For
Voya31,7720 00For
Pacific Life23,9010 00For
John Hancock19,8180 00For
Brighthouse17,1430 00For
GPS Funds I15,8390 00For
Bridge Builder Trust14,0400 00For
ProShares11,7040 00For
TIAA8,8100 00For
Northern Trust8,6860 00For
SEI7,6000 00For
Victory Capital7,3860 00For
AIG/SunAmerica6,8460 00For

Fund voting reports, all 39 managers: 7,928,522 for, 2,690 withheld, 7 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 1 asset manager voting on “Election of eight directors: Mark Stolper” at The Oncology Institute, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Kanen Wealth Management LLC3,513,1780 00For

Institutional-manager reports, all 1 managers: 3,513,178 for.

8. Elect Director: Mohit Kaushal

Outcome not verifiedFund totals may overlapDIRECTOR ELECTIONSReported outcome: Not verified

Combines 3 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 24,061,396WITHHELD: 1,514,319
Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: Election of eight directors: Mohit Kaushal

The Oncology Institute, Inc.’s own tally for this item (“Elect Director: Mohit Kaushal”): 24,061,396 for, 1,514,319 withheld, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 39 asset managers voting on “Election of eight directors: Mohit Kaushal” at The Oncology Institute, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,183,0990 75,495For
BlackRock1,378,0860 00For
World Funds Trust1,000,0000 00For
TIFF INVESTMENT PROGRAM352,8490 00For
Charles Schwab214,8900 00For
Goldman Sachs178,7260 00For
JPMorgan98,0100 00For
Equitable82,5610 00For
Lincoln Financial74,5380 00For
Fidelity43,0460 00For
AQR39,6750 00For
QUANTITATIVE MASTER SERIES LLC39,6380 00For
Global X34,5750 00For
Voya31,7720 00For
Pacific Life23,9010 00For
John Hancock19,8180 00For
Brighthouse17,1430 00For
GPS Funds I15,8390 00For
Bridge Builder Trust14,0400 00For
ProShares11,7040 00For
TIAA8,8100 00For
Northern Trust8,6860 00For
SEI7,6000 00For
Victory Capital7,3860 00For
AIG/SunAmerica6,8460 00For

Fund voting reports, all 39 managers: 7,925,293 for, 5,919 withheld, 7 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 1 asset manager voting on “Election of eight directors: Mohit Kaushal” at The Oncology Institute, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Kanen Wealth Management LLC3,513,1780 00For

Institutional-manager reports, all 1 managers: 3,513,178 for.

9. 3. Approval, on a non-binding, advisory basis, of the Company's named executive officers (the "Say-on-Pay Proposal")…

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

99% Approved · of votes cast

FOR 99%
FOR: 25,280,934AGAINST: 282,655
Details: description as filed, official tally, votes by 107 asset managers

Description as filed by funds: APPROVAL, ON A NON-BINDING, ADVISORY BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.

The Oncology Institute, Inc.’s own tally for this item (“3. Approval, on a non-binding, advisory basis, of the Company's named executive officers (the "Say-on-Pay Proposal") The Say-on-Pay Proposal”): 25,280,934 for, 282,655 against — passed, per its Form 8-K filed June 18, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3: Approval, on a non-binding, advisory basis, of the Company's named executive officers (the "Say-on-Pay Proposal") The Say-on-Pay Proposal was approved.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of The Oncology Institute, Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (2 managers, 1,716,011 for).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 39 asset managers voting on “APPROVAL, ON A NON-BINDING, ADVISORY BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at The Oncology Institute, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,188,6001 00For
BlackRock1,378,0860 00For
World Funds Trust1,000,0000 00For
TIFF INVESTMENT PROGRAM352,8490 00For
Charles Schwab214,8900 00For
Goldman Sachs178,7260 00For
JPMorgan98,0100 00For
Equitable82,5610 00For
Lincoln Financial74,5380 00For
Fidelity43,0460 00For
AQR39,6750 00For
QUANTITATIVE MASTER SERIES LLC39,6380 00For
Global X34,5750 00For
Voya31,7720 00For
Pacific Life23,9010 00For
John Hancock19,8180 00For
Brighthouse17,1430 00For
GPS Funds I15,8390 00For
Bridge Builder Trust14,0400 00For
ProShares11,7040 00For
TIAA8,8100 00For
Northern Trust8,6860 00For
SEI7,6000 00For
Victory Capital7,3860 00For
AIG/SunAmerica6,8460 00For

Fund voting reports, all 39 managers: 7,923,654 for, 7,565 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 83 asset managers voting on “APPROVAL, ON A NON-BINDING, ADVISORY BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at The Oncology Institute, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Kanen Wealth Management LLC3,513,1780 00For
DEERFIELD MANAGEMENT COMPANY, L.P.3,274,9850 00For
BlackRock802,30030,046 00For
State Street640,5412,319 00For
Ensign Peak Advisors, Inc578,8440 00For
Vanguard411,3650 00For
Northern Trust293,8302,467 00For
Mount Lucas Management LP250,0000 00For
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP212,07221,517 00Mixed
Charles Schwab214,9150 00For
GEODE CAPITAL MANAGEMENT, LLC150,4540 00For
MELLON INVESTMENTS Corp0119,359 00Against
MARSHALL WACE, LLP116,2540 00For
HighTower Advisors, LLC85,8620 00For
Goldman Sachs81,7130 00For
Lee Financial Co81,3620 00For
Capital Group70,1920 00For
AllianceBernstein61,6000 00For
JPMorgan58,4120 00For
AQR44,2130 00For
Invesco032,326 00Against
Voya31,7720 00For
Holt Capital Advisors, L.L.C. dba Holt Capital Partners, L.P29,5340 00For
Prudential/PGIM26,5250 00For
State of Wyoming20,2620 00For

Institutional-manager reports, all 83 managers: 11,266,826 for, 227,682 against, 9,094 1 year. Showing the 25 largest; see all in the interactive database.

10. APPROVAL, ON A NON-BINDING, ADVISORY BASIS, OF THE PREFERRED FREQUENCY OF FUTURE ADVISORY VOTES ON THE COMPENSATION OF…

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

99.9% Fund and manager reports combined; may count the same shares twice · no official result

FOR1 YEAR
Details: description as filed, votes by 107 asset managers

Description as filed by funds: APPROVAL, ON A NON-BINDING, ADVISORY BASIS, OF THE PREFERRED FREQUENCY OF FUTURE ADVISORY VOTES ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 39 asset managers voting on “APPROVAL, ON A NON-BINDING, ADVISORY BASIS, OF THE PREFERRED FREQUENCY OF FUTURE ADVISORY VOTES ON THE COMPENS” at The Oncology Institute, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard00 00--
BlackRock00 00--
World Funds Trust00 00--
TIFF INVESTMENT PROGRAM00 00--
Charles Schwab00 00--
Goldman Sachs00 00--
JPMorgan00 00--
Equitable00 00--
Lincoln Financial00 00--
Fidelity00 00--
AQR00 00--
QUANTITATIVE MASTER SERIES LLC00 00--
Global X00 00--
Voya00 00--
Pacific Life00 00--
John Hancock00 00--
Brighthouse11,1090 00For
GPS Funds I00 00--
Bridge Builder Trust00 00--
ProShares00 00--
TIAA00 00--
Northern Trust00 00--
SEI00 00--
Victory Capital00 00--
AIG/SunAmerica00 00--

Fund voting reports, all 39 managers: 11,109 for, 7,919,995 1 year, 115 unknown. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 83 asset managers voting on “APPROVAL, ON A NON-BINDING, ADVISORY BASIS, OF THE PREFERRED FREQUENCY OF FUTURE ADVISORY VOTES ON THE COMPENS” at The Oncology Institute, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Kanen Wealth Management LLC3,513,1780 00For
DEERFIELD MANAGEMENT COMPANY, L.P.00 00--
BlackRock00 00--
State Street00 00--
Ensign Peak Advisors, Inc00 00--
Vanguard00 00--
Northern Trust00 00--
Mount Lucas Management LP00 00--
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP00 00--
Charles Schwab00 00--
GEODE CAPITAL MANAGEMENT, LLC00 00--
MELLON INVESTMENTS Corp00 00--
MARSHALL WACE, LLP00 00--
HighTower Advisors, LLC00 00--
Goldman Sachs00 00--
Lee Financial Co00 00--
Capital Group00 00--
AllianceBernstein00 00--
JPMorgan00 00--
AQR00 00--
Invesco00 00--
Voya00 00--
Holt Capital Advisors, L.L.C. dba Holt Capital Partners, L.P00 00--
Prudential/PGIM00 00--
State of Wyoming00 00--

Institutional-manager reports, all 83 managers: 3,521,902 for, 370 against, 7,401,486 1 year, 579,844 3 year. Showing the 25 largest; see all in the interactive database.

11. 2. Ratification of the Appointment of Independent Registered Public Accountants The ratification of the appointment of…

Official resultFund totals may overlapAUDIT-RELATEDReported outcome: Approved

99.9% Approved · of votes cast

FOR 99.9%
FOR: 75,098,890AGAINST: 37,257
Details: description as filed, official tally, votes by 40 asset managers

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF BDO AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR 2026.

The Oncology Institute, Inc.’s own tally for this item (“2. Ratification of the Appointment of Independent Registered Public Accountants The ratification of the appointment of BDO USA, P.C”): 75,098,890 for, 37,257 against — passed, per its Form 8-K filed June 18, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2: Ratification of the Appointment of Independent Registered Public Accountants The ratification of the appointment of BDO USA, P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 39 asset managers voting on “RATIFICATION OF THE APPOINTMENT OF BDO AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR” at The Oncology Institute, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,188,6010 00For
BlackRock1,378,0860 00For
World Funds Trust1,000,0000 00For
TIFF INVESTMENT PROGRAM352,8490 00For
Charles Schwab214,8900 00For
Goldman Sachs178,7260 00For
JPMorgan98,0100 00For
Equitable82,5610 00For
Lincoln Financial74,5380 00For
Fidelity43,0460 00For
AQR39,6750 00For
QUANTITATIVE MASTER SERIES LLC39,6380 00For
Global X34,5750 00For
Voya31,7720 00For
Pacific Life23,9010 00For
John Hancock19,8180 00For
Brighthouse17,1430 00For
GPS Funds I15,8390 00For
Bridge Builder Trust14,0400 00For
ProShares11,7040 00For
TIAA8,8100 00For
Northern Trust8,6860 00For
SEI7,6000 00For
Victory Capital7,3860 00For
AIG/SunAmerica6,8460 00For

Fund voting reports, all 39 managers: 7,931,219 for. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 1 asset manager voting on “RATIFICATION OF THE APPOINTMENT OF BDO AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR” at The Oncology Institute, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Kanen Wealth Management LLC3,513,1780 00For

Institutional-manager reports, all 1 managers: 3,513,178 for.

Largest The Oncology Institute, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 99,982,933 shares outstanding at the time of that meeting.

Fund voting reports: top The Oncology Institute, Inc. shareholders by shares voted on “APPROVAL, ON A NON-BINDING, ADVISORY BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED…”, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 4.19%
2BlackRock 1.38%
3World Funds Trust 1.00%
4TIFF INVESTMENT PROGRAM 0.35%
5Charles Schwab 0.21%
6Goldman Sachs 0.18%
7JPMorgan 0.10%
8Equitable 0.08%
9Lincoln Financial 0.07%
10Fidelity 0.04%
Institutional-manager reports: top The Oncology Institute, Inc. shareholders by shares voted on “APPROVAL, ON A NON-BINDING, ADVISORY BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED…”, 2025-2026
#Asset manager % of shares outstanding
1Kanen Wealth Management LLC 3.51%
2DEERFIELD MANAGEMENT COMPANY, L.P. 3.28%
3BlackRock 0.83%
4State Street 0.64%
5Ensign Peak Advisors, Inc 0.58%
6Vanguard 0.41%
7Northern Trust 0.30%
8Mount Lucas Management LP 0.25%
9ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.23%
10Charles Schwab 0.21%

Reported The Oncology Institute, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

The Oncology Institute, Inc. holdings and ownership disclosed for the 2025-2026 proxy season
Holder % outstanding Disclosure
Jorey Chernett 10.50% DEF14A
Chernett Jorey 10.12% 13G
Parian Global TOI LP 9.38% DEF14A
M33 Growth I L.P. 5.00% 13D
Vanguard Group 4.75% 13F
BlackRock 4.42% 13F
Citadel Advisors 2.36% 13F
Daniel Virnich 2.21% DEF14A
Geode Capital 1.76% 13F
State Street 1.46% 13F

Percentages above are of 99,982,933 shares outstanding, as reported by The Oncology Institute, Inc. on its Form 10-Q dated April 30, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from The Oncology Institute, Inc.’s 10-Q dated April 30, 2026. This page is a static snapshot rebuilt weekly on October 25, 2026; a live search always shows the current data.

At The Oncology Institute, Inc.'s shareholder meeting held June 17, 2026, in the 2025-2026 proxy season, 109 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,337 separate fund positions. Their filings are grouped here into 11 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — APPROVAL, ON A NON-BINDING, ADVISORY BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED… — The Oncology Institute, Inc.'s filing reports the proposal as approved, with 99% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: The Oncology Institute, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 18, 2026.

The Oncology Institute, Inc. proxy season coverage: 2025-2026 (this page).

Download data (CSV): ballot items · votes by manager · column guide.